Skip to main content

Market Overview

23 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Share:

Gainers

  • Sophiris Bio, Inc. (NASDAQ: SPHS) shares surged 20.8% to $0.75 during Wednesday's pre-market session. The market value of their outstanding shares is at $29.9 million.
  • Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA) shares moved upwards by 14.1% to $0.13. The market cap stands at $346.5 million. The most recent rating by BMO Capital, on September 05, is at Outperform, with a price target of $3.00.
  • PhaseBio Pharmaceuticals, Inc. (NASDAQ: PHAS) shares rose 13.3% to $4.43. The most recent rating by Stifel, on September 09, is at Buy, with a price target of $17.00.
  • Vaxart, Inc. (NASDAQ: VXRT) stock increased by 12.2% to $0.55. The market cap seems to be at $10.5 million.
  • Guardion Health Sciences, Inc. (NASDAQ: GHSI) shares rose 7.2% to $0.85.
  • Bio-Path Holdings, Inc. (NASDAQ: BPTH) stock surged 6.6% to $11.20. The market cap stands at $4.5 million. The most recent rating by H.C. Wainwright, on July 16, is at Buy, with a price target of $28.00.
  • T2 Biosystems, Inc. (NASDAQ: TTOO) stock increased by 6.0% to $3.00. The market cap stands at $323.6 million. According to the most recent rating by Janney Capital, on September 12, the current rating is at Buy.
  • Pacira BioSciences, Inc. (NASDAQ: PCRX) shares increased by 5.6% to $40.00. The market cap stands at $2.8 billion. The most recent rating by BMO Capital, on August 09, is at Market Perform, with a price target of $43.00.
  • Intec Pharma, Inc. (NASDAQ: NTEC) shares increased by 5.5% to $0.90. According to the most recent rating by H.C. Wainwright, on August 07, the current rating is at Neutral.
  • Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) shares rose 5.4% to $3.80. The market cap stands at $303.7 million.
  • VBI Vaccines, Inc. (NASDAQ: VBIV) stock increased by 4.3% to $0.55. The market cap stands at $59.9 million.
  • GW Pharmaceuticals, Inc. (NASDAQ: GWPH) shares surged 3.6% to $122.95.
  • Cellectar Biosciences, Inc. (NASDAQ: CLRB) shares increased by 3.6% to $2.30. The market value of their outstanding shares is at $11.1 million. The most recent rating by Roth Capital, on September 13, is at Buy, with a price target of $11.00.
  • Ovid Therapeutics, Inc. (NASDAQ: OVID) shares rose 3.2% to $3.20. The market cap seems to be at $174.0 million. The most recent rating by Citi, on September 24, is at Buy, with a price target of $10.00.
  • Acasti Pharma, Inc. (NASDAQ: ACST) shares moved upwards by 3.0% to $2.09. The market cap seems to be at $165.8 million. The most recent rating by B. Riley FBR, on August 29, is at Buy, with a price target of $7.75.
  • Viveve Medical, Inc. (NASDAQ: VIVE) shares rose 2.6% to $5.80. The market cap stands at $40.7 million. According to the most recent rating by Ladenburg Thalmann, on July 24, the current rating is at Neutral.

 

Losers

  • AzurRx BioPharma, Inc. (NASDAQ: AZRX) shares fell 36.0% to $0.57 during Wednesday's pre-market session. The market value of their outstanding shares is at $26.3 million.
  • Lannett, Inc. (NYSE: LCI) shares plummeted 15.5% to $11.74. The market cap seems to be at $117.3 million. The most recent rating by SunTrust Robinson Humphrey, on September 18, is at Hold, with a price target of $14.00.
  • Jaguar Health, Inc. (NASDAQ: JAGX) shares plummeted 9.4% to $1.35. The market cap seems to be at $9.3 million. The most recent rating by Ladenburg Thalmann, on September 12, is at Buy, with a price target of $5.00.
  • Advaxis, Inc. (NASDAQ: ADXS) stock plummeted 6.2% to $0.23. The market value of their outstanding shares is at $77.0 million.
  • Genfit, Inc. (NASDAQ: GNFT) shares fell 3.2% to $16.66. The market cap seems to be at $638.7 million.
  • Endo International, Inc. (NASDAQ: ENDP) stock fell 3.2% to $3.06. The market cap stands at $644.6 million. The most recent rating by Morgan Stanley, on July 15, is at Underweight, with a price target of $3.00.
  • Fresenius Medical Care, Inc. (NYSE: FMS) shares plummeted 2.2% to $33.68. The market cap stands at $3.3 billion. According to the most recent rating by BTIG, on August 01, the current rating is at Neutral.
 

Related Articles (ACHN + ACST)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com